These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29955881)

  • 1. Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina.
    Taverna CG; Córdoba S; Vivot M; Szusz W; Vivot W; Bosco-Borgeat ME; Davel G
    Med Mycol; 2019 Apr; 57(3):314-323. PubMed ID: 29955881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.
    Castanheira M; Woosley LN; Diekema DJ; Jones RN; Pfaller MA
    J Clin Microbiol; 2013 Jan; 51(1):117-24. PubMed ID: 23100350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.
    Jensen RH; Arendrup MC
    J Clin Microbiol; 2011 Feb; 49(2):549-56. PubMed ID: 21147953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system.
    Kim SH; Shin JH; Mok JH; Kim SY; Song SA; Kim HR; Kook JK; Chang YH; Bae IK; Lee K
    Biomed Res Int; 2014; 2014():250408. PubMed ID: 24977144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals.
    Eddouzi J; Lohberger A; Vogne C; Manai M; Sanglard D
    Med Mycol; 2013 Oct; 51(7):737-46. PubMed ID: 23768242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeasts from Scarlet ibises (Eudocimus ruber): A focus on monitoring the antifungal susceptibility of Candida famata and closely related species.
    Brilhante RSN; Silva ALD; Monteiro FOB; Guedes GMM; Sales JA; Oliveira JS; Maia Junior JE; Miranda SA; Sidrim JJC; Alencar LP; Castelo-Branco DSCM; Cordeiro RA; Pereira Neto WA; Rocha MFG
    Med Mycol; 2017 Oct; 55(7):725-732. PubMed ID: 28204651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of Debaryomyces hansenii and Candida famata by rRNA gene intergenic spacer fingerprinting and reassessment of phylogenetic relationships among D. hansenii, C. famata, D. fabryi, C. flareri (=D. subglobosus) and D. prosopidis: description of D. vietnamensis sp. nov. closely related to D. nepalensis.
    Nguyen HV; Gaillardin C; Neuvéglise C
    FEMS Yeast Res; 2009 Jun; 9(4):641-62. PubMed ID: 19385997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Uncommon
    Kim TH; Kweon OJ; Kim HR; Lee MK
    J Microbiol Biotechnol; 2016 Dec; 26(12):2206-2213. PubMed ID: 27713213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.
    Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A
    Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
    Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
    Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.
    Hou X; Xiao M; Chen SC; Wang H; Cheng JW; Chen XX; Xu ZP; Fan X; Kong F; Xu YC
    J Clin Microbiol; 2016 Nov; 54(11):2676-2680. PubMed ID: 27535688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia.
    Belgacem S; Chebil W; Ben Salem S; Babba O; Mastouri M; Babba H
    Med Mycol; 2024 Aug; 62(8):. PubMed ID: 38986508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.
    Chen CY; Huang SY; Tang JL; Tsay W; Yao M; Ko BS; Chou WC; Tien HF; Hsueh PR
    J Antimicrob Chemother; 2013 Nov; 68(11):2632-5. PubMed ID: 23766486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.
    Hu Z; Zhang J; Chen Z; Jin Z; Leng P; Zhou J; Xie X
    Braz J Microbiol; 2019 Jan; 50(1):99-105. PubMed ID: 30637643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods.
    Cornet M; Sendid B; Fradin C; Gaillardin C; Poulain D; Nguyen HV
    J Mol Diagn; 2011 Jan; 13(1):12-22. PubMed ID: 21227390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida inconspicua and Candida norvegensis: new insights into identification in relation to sexual reproduction and genome organization.
    Guitard J; Atanasova R; Brossas JY; Meyer I; Gits M; Marinach C; Vellaissamy S; Angoulvant A; Mazier D; Hennequin C
    J Clin Microbiol; 2015 May; 53(5):1655-61. PubMed ID: 25762773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods.
    Huang YS; Wang FD; Chen YC; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Liu WL
    J Formos Med Assoc; 2021 May; 120(5):1179-1187. PubMed ID: 33250336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of MALDI-TOF MS for requalification of a Candida clinical isolates culture collection.
    Lima-Neto R; Santos C; Lima N; Sampaio P; Pais C; Neves RP
    Braz J Microbiol; 2014; 45(2):515-22. PubMed ID: 25242936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.